News

As we move into fall, you might be feeling at the top of your game — you’ve made it a priority to exercise regularly, eat a balanced diet and get stress under control. Last summer, you barely had a sniffle. Plus, you’re one of those people who just doesn’t get sick very often. You might be wondering: Can I skip getting a flu shot?

It’s no secret that when women are healthy, families and communities thrive. But from menstruation to menopause, women face many distinct — and sometimes complex — health events that require care, understanding and partnership from a health care provider.

Think of the word “infertility,” and you might picture a couple without children struggling to get pregnant or stay pregnant. But there is another set of people — those who have successfully conceived and given birth to one or more children — who struggle with infertility, too. Called secondary infertility, the condition often carries an extra burden: Those affected by it might feel guilty over wanting another child; those close to them may be unsympathetic because they are already a parent; or frustrated because getting pregnant the first (or second) time was relatively easy.

Vaccinations are a cornerstone of adult health, offering protection against multiple diseases that can affect quality of life and longevity. As we age, the immunity we gained from childhood vaccinations can wane, leaving us vulnerable to infections. Moreover, lifestyle changes, travel and age-related health changes introduce new risks that adult vaccinations can make less severe or painful.

With the flu season upon us — along with fall allergies and new strains of COVID-19 — it can be hard to tell all the symptoms apart.

Learn the differences among symptoms and why getting the flu vaccine can help keep you and those around you safe.

Is it the flu?

The symptom checker outlines differences and similarities among flu, colds, COVID-19 and seasonal allergies.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.